Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will investigate the effect on ambulatory blood pressure of lumiracoxib 100 mg
once daily versus ibuprofen 600 mg three times a day in osteoarthritis patients with
controlled hypertension.